Cabergoline for migraine prevention (PROTECT): Protocol for a randomized, placebo-controlled, double-blind trial.

Saved in:
Bibliographic Details
Title: Cabergoline for migraine prevention (PROTECT): Protocol for a randomized, placebo-controlled, double-blind trial.
Authors: Hjelholt, Astrid Johannesson1,2,3 (AUTHOR) ajh@clin.au.dk, Laugesen, Kristina2,4,5 (AUTHOR), Tei, Randi Maria Hanghøj1,2 (AUTHOR), Kasch, Helge2 (AUTHOR), Diener, Hans-Christoph6 (AUTHOR), Jørgensen, Jens Otto Lunde1,2 (AUTHOR)
Source: Cephalalgia Reports. 6/25/2026, Vol. 9, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:25158163
DOI:10.1177/25158163261464939